Intec Pharma OverviewIntec Pharma EBIT
EBIT (Earnings Before Interest and Taxes) analysis for NTEC.
Quarterly EBIT
-$4.18M
↓ 9.69% YoY
As of Mar 31, 2021
Annual EBIT (TTM)
-$14.37M
↑ 64.2% YoY
Trailing 12 months ending Mar 31, 2021
Intec Pharma OverviewEBIT (Earnings Before Interest and Taxes) analysis for NTEC.
As of Mar 31, 2021
Trailing 12 months ending Mar 31, 2021